ARTICLE | Clinical News
Actimmune: Began Phase III trial
April 17, 2000 7:00 AM UTC
InterMune Pharmaceuticals Inc. (ITMN), Burlingame, Calif. Product: Actimmune Business: Pulmonary Therapeutic category: Immune modulation Target: Unknown Description: Interferon gamma-1b Indication: T...